MACA MADDER DYERS MADDER

MACA, PERUVIAN GINSENG (Lepidium meyenii Walp.) ++

Synonym:
Lepidium peruvianum Chacon.

Activities (Maca):
Antiseptic (f; DAZ); Aphrodisiac (1; X11561196; X11297856); Cicatrizant (f; DAZ); Emmenagogue (f; DAZ); Lipogenic (1; X11048583); Memorigenic (f; EB55:255); Spermatogenic (1; X11561196); Tonic (f; X11297856); Vulnerary (f; DAZ).

Indications (Maca):
Anemia (f; EB55:255); Cancer (1; EB55:255); Cancer, breast (1; EB55:255); Cancer, liver (1; EB55:255); Cancer, stomach (1; EB55:255); Debility (f; X11297856); Depression (f; EB55:255); Gastrosis (1; EB55:255); Hepatosis (1; EB55:255); Impotence (1; X11561196; X11297856); High Blood Pressure (f; DAZ); HIV (f; EB55:255); Infertility (1; X11561196); Leukemia (f; EB55:255); Mastosis (1; EB55:255); Pulmonosis (f; DAZ); Stress (1; EB55:255); Wound (f; DAZ).

Dosages (Maca) :
Maca is traditionally eaten as food in the high Andes. For the herb market, Maca is dried and encapsulated. 300 mg root extract, standardized for 0.6% macamides and macaenes, in a 145 mg base of Maca root, 3 ×/day (NH); 500 mg root 3–6 ×/day (NH). Experimental animal doses: 75 mg root extract/kg (X11297856); 66.7 mg root extract/ml (X11561196); in fairly large quantities.

Contraindications, Interactions, and Side Effects (Maca)
Not covered (AHP; KOM; PH2). Some importers recommend a periodic break from Maca consumption.


MADDER, DYER’S MADDER (Rubia tinctorum L.) X

Activities (Madder) :
Astringent (f; WOI); Carcinogenic (1; FNF); Digestive (f; WOI); Diuretic (f; EFS; HHB; WOI); Emmenagogue (f; EFS); Genotoxic (1; FNF); Litholytic (f; PH2; WOI); Mutagenic (1; PH2); Poison (1; PH2); Tonic (f; EFS; HHB).

Indications (Madder):
Amenorrhea (f; HHB; MAD); Anemia (f; HHB; MAD); Arthrosis (f; HHB; WOI); Bladder Stone (f; HHB); Bruise (f; MAD); Calculosis (f; WOI); Cancer (f; JLH); Cancer, bladder (f; JLH); Cancer, kidney (f; JLH); Cancer, liver (f; JLH); Cancer, skin (f; JLH); Cancer, stomach (f; JLH); Cancer, uterus (f; JLH); Chlorosis (f; MAD); Cholecystosis (f; WOI); Cystosis (f; HHB); Decubitis (f; WOI); Dermatosis (f; JLH); Diarrhea (f; HHB); Dropsy (f; JLH); Dysentery (f; MAD); Dysmenorrhea (f; MAD; PNC); Dysuria (f; PNC); Enterosis (f; MAD); Enuresis (f; MAD); Gastrosis (f; JLH; MAD); Gout (f; MAD); Hepatosis (f; HHB; MAD; PNC); Induration (f; JLH); Jaundice (f; MAD); Kidney Stone (f; PH2); Lichen (f; MAD); Malaria (f; MAD); Nephrosis (f; HHB); Pyelonephrosis (f; MAD); Scab (f; MAD); Scrofula (f; MAD); Sore (f; HHB); Splenosis (f; HHB; JLH; KAB; MAD); Stone (f; HHB; PH2; WOI); Synovia (f; MAD); Tuberculosis (f; HHB; MAD); Uterosis (f; JLH); Water Retention (f; EFS; HHB; WOI); Wound (f; HHB).

Dosages (Madder) :
Do not take it (JAD; PH2); 30 grains root 3–4 ×/day (FEL); 1 g powdered root 3 ×/day (MAD).

Contraindications, Interactions, and Side Effects (Madder) :
The court is still out on whether or not alizarin, lucidin, and purpurin from Rubia tinctorum exert a disintegrating effect on the surface of bladder and kidney stones containing calcium. Since extracts of the root are mutagenic and contain genotoxic and tumorigenic compounds, it is not to be recommended (De Smet, 1993). “Drug should not be administered” (PH2).